4.6 Article

Genetic Determinants of Trabecular and Cortical Volumetric Bone Mineral Densities and Bone Microstructure

期刊

PLOS GENETICS
卷 9, 期 2, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pgen.1003247

关键词

-

资金

  1. Wellcome Trust [092731, 079960, WT083431MA]
  2. German Bundesministerium fuer Forschung und Technology [01 AK 803, 01 IG 07015]
  3. Medical Research Council New Investigator Award [MRC G0800582]
  4. Swedish Research Council
  5. Swedish Foundation for Strategic Research
  6. ALF/LUA research grants from Sahlgrenska University Hospital
  7. King Gustav V and Queen Victoria Freemason Foundation
  8. Lundberg Foundation
  9. Torsten and Ragnar Soderberg's Foundation
  10. Novo Nordisk Foundation
  11. European Commission [HEALTH-F2-2008-201865-GEFOS]
  12. Academy of Finland [126925, 121584, 124282, 129378, 117797, 216310, 41071]
  13. Social Insurance Institution of Finland
  14. Kuopio, Tampere, and Turku University Hospital Medical Funds
  15. Juho Vainio Foundation
  16. Paavo Nurmi Foundation
  17. Finnish Foundation of Cardiovascular Research
  18. Finnish Cultural Foundation
  19. Sigrid Juselius Foundation
  20. Tampere Tuberculosis Foundation
  21. Emil Aaltonen Foundation
  22. Academy of Finland (AKA) [216310, 216310] Funding Source: Academy of Finland (AKA)
  23. MRC [MC_UU_12013/4, G0800582] Funding Source: UKRI
  24. Medical Research Council [G9815508, MC_UU_12013/4, G0800582] Funding Source: researchfish
  25. Novo Nordisk Fonden [NNF13OC0005785] Funding Source: researchfish

向作者/读者索取更多资源

Most previous genetic epidemiology studies within the field of osteoporosis have focused on the genetics of the complex trait areal bone mineral density (aBMD), not being able to differentiate genetic determinants of cortical volumetric BMD (vBMD), trabecular vBMD, and bone microstructural traits. The objective of this study was to separately identify genetic determinants of these bone traits as analysed by peripheral quantitative computed tomography (pQCT). Separate GWA meta-analyses for cortical and trabecular vBMDs were performed. The cortical vBMD GWA meta-analysis (n = 5,878) followed by replication (n = 1,052) identified genetic variants in four separate loci reaching genome-wide significance (RANKL, rs1021188, p = 3.6x10(-14); LOC285735, rs271170, p = 2.7x10(-12); OPG, rs7839059, p = 1.2x10(-10); and ESR1/C6orf97, rs6909279, p = 1.1x10(-9)). The trabecular vBMD GWA meta-analysis (n = 2,500) followed by replication (n = 1,022) identified one locus reaching genome-wide significance (FMN2/GREM2, rs9287237, p = 1.9x10(-9)). High-resolution pQCT analyses, giving information about bone microstructure, were available in a subset of the GOOD cohort (n = 729). rs1021188 was significantly associated with cortical porosity while rs9287237 was significantly associated with trabecular bone fraction. The genetic variant in the FMN2/GREM2 locus was associated with fracture risk in the MrOS Sweden cohort (HR per extra T allele 0.75, 95% confidence interval 0.60-0.93) and GREM2 expression in human osteoblasts. In conclusion, five genetic loci associated with trabecular or cortical vBMD were identified. Two of these (FMN2/GREM2 and LOC285735) are novel bone-related loci, while the other three have previously been reported to be associated with aBMD. The genetic variants associated with cortical and trabecular bone parameters differed, underscoring the complexity of the genetics of bone parameters. We propose that a genetic variant in the RANKL locus influences cortical vBMD, at least partly, via effects on cortical porosity, and that a genetic variant in the FMN2/GREM2 locus influences GREM2 expression in osteoblasts and thereby trabecular number and thickness as well as fracture risk.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据